Pashtoon Murtaza Kasi

41PUBLICATIONS
229CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 26, 2026
Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial.

|Jun 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|Jun 03, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.

|Apr 07, 2026
The distinct roles of Negativicoccus and Fusobacterium in proximal- and late-onset colorectal cancer.

Soham Ali, Apurva J Patel, Peter C Lehman

|Mar 26, 2026
Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer.

Fatima Qadri, Maaz Khan Afghan, Areeb Lutfi

|Jan 12, 2026
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis.

John H Strickler, Andrea Cercek, Salvatore Siena

Pageof 7

Frequent Collaborators

4 joint publications

Alexey Aleshin

3 joint publications

Alexa B Schrock

3 joint publications

Shubham Pant

3 joint publications

Manish Shah